Our Research
The focus of our research is developing viral vector-based gene replacement strategies for the treatment of inherited ocular disease.
Play Video
Meet Dr. Boye
Dr. Shannon E. Boye received her B.S. in marine biology with a minor in chemistry from Fairleigh Dickinson University in 2001. She graduated with a Ph.D. in Neuroscience from the University of Florida in 2006. Her thesis work involved developing viral vectors for the treatment of retinal disease, specifically GUCY2D Leber Congenital Amaurosis (LCA1).
Recent Lab News
Atsena Therapeutics Receives FDA Designation for…
The company was created by ocular gene therapy pioneers Dr. Shannon Boye and Associate Scientist Sanford Boye, who also run the Shannon E. Boye…
Tech Tuesday: Gene Therapy
In this week’s Tech Tuesday, we meet Dr. Shannon Boye, a researcher at the University of Florida, who is working to use gene therapy to restore or…
UF Health researchers’ gene editing approach…
Using a type of “genetic scissors,” University of Florida Health researchers have successfully removed and replaced a malfunctioning gene that…
